SCHEMBL1632131

SCHEMBL1632131

CC(C)Oc1cccc2cnc(Nc3cccc(S(N)(=O)=O)c3)nc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BMPR2 Q13873 6/20 0.52
CDK2 P24941 14/20 0.52
CDK1 P06493 13/20 0.52
CCNT1 O60563 10/20 0.52
CCNB1 P14635 10/20 0.52
CDK9 P50750 10/20 0.52
CCNA2 P20248 8/20 0.52
CDK5 Q00535 6/20 0.52
CCNE1 P24864 5/20 0.52
CDK5R1 Q15078 3/20 0.52
FLT3 P36888 2/20 0.52
CCND3 P30281 1/20 0.52
CDK6 Q00534 1/20 0.52
AURKA O14965 3/20 0.51
DCLK1 O15075 3/20 0.51
PDPK1 O15530 3/20 0.51
JAK2 O60674 3/20 0.51
ROCK2 O75116 3/20 0.51
MAP4K4 O95819 3/20 0.51
EGFR P00533 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634282 0.90 ACVR1 (0.52) CDK2CDK1CCNT1CCNB1CDK9
SCHEMBL1632814 0.89 CDK2 (0.52) CDK2CDK1CCNT1CCNB1CDK9
SCHEMBL1633703 0.85 AURKA (0.48) BMPR2CDK2CDK1CCNT1CCNB1
SCHEMBL1633395 0.81 CDK2 (0.49) CDK2CDK1CCNT1CCNB1CDK9
SCHEMBL1632161 0.80 CDK1 (0.59) BMPR2CDK2CDK1CCNT1CCNB1
SCHEMBL1632891 0.79 JAK2 (0.48) CDK2CDK1CCNB1CDK9CCNA2
SCHEMBL1631342 0.79 CDK2 (0.45) CDK2CDK1CCNT1CCNB1CDK9
SCHEMBL1634895 0.78 CA1 (0.51) CDK2CDK5CDK5R1
SCHEMBL1636291 0.78 JAK3 (0.56) BMPR2CDK2CDK1CCNT1CCNB1
SCHEMBL13498292 0.78 JAK3 (0.63) BMPR2CDK2CDK1CCNT1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed